news, page-3

I called the MD, I must say It was demoralising speaking to him basicly coramsine is finished as they feel it is too expensive to take it forward for FDA approval.
They are looking at other medical business deals to persue but arent wanting to burn too much cash.
Personally I would like the company wound up and the moeny returned to investers as there is no vision, and the employees are just wasting my investment.